Pilmore H
Renal Medicine, Auckland City Hospital, Park Road, Grafton, Auckland 00001, New Zealand.
Am J Transplant. 2006 Apr;6(4):659-65. doi: 10.1111/j.1600-6143.2006.01253.x.
Cardiac death is common in patients with end-stage renal failure. Screening for coronary artery disease prior to renal transplantation is advisable in high-risk patients. The optimal screening test has not been defined; however, myocardial perfusion studies are more sensitive than exercise electrocardiography and are less invasive than coronary angiography, which remains the gold standard. The management of coronary artery disease prior to transplantation is contentious. Revascularization of coronary artery stenoses is associated with high mortality and morbidity in the renal failure population, and there is little data to indicate that most patients with asymptomatic coronary lesions will benefit from prophylactic coronary intervention. In addition, beta-blockers and aspirin are under-utilized in the renal population. This paper reviews the literature and proposes algorithms for the cardiac assessment and management of patients prior to renal transplantation.
心脏性死亡在终末期肾衰竭患者中很常见。对于高危患者,在肾移植前筛查冠状动脉疾病是可取的。最佳筛查试验尚未确定;然而,心肌灌注研究比运动心电图更敏感,且比冠状动脉造影侵入性小,冠状动脉造影仍是金标准。移植前冠状动脉疾病的管理存在争议。冠状动脉狭窄的血运重建在肾衰竭人群中与高死亡率和发病率相关,而且几乎没有数据表明大多数无症状冠状动脉病变患者将从预防性冠状动脉干预中获益。此外,β受体阻滞剂和阿司匹林在肾衰竭人群中的使用不足。本文回顾了文献,并提出了肾移植前患者心脏评估和管理的算法。